TARSONSTarsons Products Limited
Healthcare · Medical Instruments & Supplies · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹281.35
▼ 2.12%Average
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,529.40
P/E106.46
P/B2.40
PEG—
ROE %2.27
ROCE %2.10
Debt / Equity0.62
EPS2.70
Revenue Growth %7.30
Profit Growth %-58.90
Dividend Yield %0.00
Promoter Holding %73.87
FII Holding %0.15
DII Holding %—
Beta0.34
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 80% | ₹281.35 | ₹264.93 | ₹329.80 | 2.95 |
HOLDConviction 55%
The picture
- • Debt/Equity: 0.62
- • Promoter holding: 73.9%
- • RSI: 54
- • Price vs EMA21: above
- • Price vs SMA50: above
- • 1-month vs NIFTY: +6.8% relative
- • Pullback to 21-EMA signal (setup quality 80%)
Bull case
- • Debt/Equity: 0.62
- • Promoter holding: 73.9%
- • RSI: 54
- • Price vs EMA21: above
Bear case
- • Revenue growth: 7.3% YoY
- • Profit growth: -58.9% YoY
- • MACD: bearish
- • Volume: 0.1x 20-day average
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: 7.3% YoY
- • Profit growth: -58.9% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹281.35
Stop Loss
₹242.55
risk 13.8%
Target 1 (1.5R)
₹339.55
+20.7%
Target 2 (3R)
₹397.75
+41.4%
Support (20d)
₹245.00
Resistance (52w)
₹395.45
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹38.80/share
ATR (volatility)
₹16.42
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹16.42). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
25
Technical
66
Momentum
72
Risk (safety)
44